๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Pressure Sensing Sheath Blood Pressure Monitoring Compared to Traditional Methods in Interventional Procedures
NCT07257367Blood Pressure Monitoring, Neuroendovascular Procedures
Shanghai Fourth People's Hospital Tongji University
Observational
50
Shanghai
2025-08-01
Not yet open
Transparent Cap-Assisted Colonoscopy Combined With Computer-Aided Detection in Improving the Detection Rate of Colorectal Adenomas
NCT07097350Colorectal Adenoma
Fudan University
Not applicable
524
Shanghai
2025-08-01
Not yet open
Comparison of Initial Treatment for Carpal Tunnel Syndrome Related to Rheumatic Diseases: Corticosteroid Injection Versus Nighttime Splinting
NCT07042282Carpal Tunnel Syndrome (CTS), Rheumatic Diseases
Yun Qian
Not applicable
248
Jinjiang, Yancheng, Shanghai
2025-08-01
Active, closed
Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study
NCT07149441Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), Fecal Microbiota Transplantation
Shanghai 10th People's Hospital
Not applicable
94
Shanghai
2025-08-01
Not yet open
Reduced Intensity Conditioning for MDS
NCT07085156MDS
Ruijin Hospital
Phase 2
45
Shanghai
2025-08-01
Recruiting
hAM for Inferior RRD
NCT07081945Rhegmatogenous Retinal Detachment
Eye & ENT Hospital of Fudan University
Not applicable
50
Shanghai
2025-08-01
Not yet open
Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033
NCT07097948Postoperative Incidental Small Cell Lung Cancer, Toripalimab Adjuvant Therapy Evaluation
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
40
Shanghai
2025-08
Not yet open
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
NCT07024277Neuroendocrine Prostate Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2
60
Shanghai
2025-08
Recruiting
A Clinical Study of GO306 in Patients With Advanced Solid Tumors
NCT07128914Solid Tumor Malignancies
GeneSail Biotech (Shanghai) Co., Ltd.
Phase 1
32
Hefei, Fuzhou, Shenzhen, Zhengzhou, Changsha, Shanghai
2025-07-31
Active, closed
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
NCT07029711Severe Alopecia Areata
Pfizer
Phase 3
208
Beijing, Chongqing, Guangzhou, Changsha, Shanghai, Chengdu, Kunming, Hangzhou
2025-07-31
Not yet open
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
NCT07086326NSCLC, Neoadjuvant Therapy, Immunotherapy, AK112
Yang Fan, MD
Phase 2
164
Beijing, Changsha, Shanghai, Xiโ€™an, Hangzhou
2025-07-31
Not yet open
Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
NCT07088588Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
105
Shanghai
2025-07-31
Recruiting
Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors
NCT07146672Solid Tumor Cancer
Shanghai Cell Therapy Group Co.,Ltd
Phase 1/2
12
Shanghai
2025-07-31
Recruiting
Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogramโ‰ฅ7%
NCT07115992Prostate Cancer, Prostate Adenoma
Ruijin Hospital
Not applicable
270
Shanghai
2025-07-30
Not yet open
Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD
NCT07088744Gastric Cancer (Diagnosis), Gastric High-grade Intraepithelial Neoplasia, Gastric Low-grade Intraepithelial Neoplasia, Gastritis
Changhai Hospital
Observational
169
Nanning, Shenyang, Chengdu, Shanghai
2025-07-30
Recruiting
Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Libertyยฎ Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
NCT07145463Aortic Valve Stenosis
Shanghai Zhongshan Hospital
Not applicable
232
Shanghai
2025-07-30
Recruiting
A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma
NCT06902389Advanced Hepatocellular Carcinoma (HCC)
Eastern Hepatobiliary Surgery Hospital
Phase 1/2
30
Shanghai
2025-07-30
Recruiting
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors
NCT07056556Non-small Cell Lung Cancer, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
31
Shanghai
2025-07-30
Recruiting
A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.
NCT07010107Reflux Esophagitis (RE)
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 3
500
Shanghai
2025-07-30
Recruiting
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
NCT07088211Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
39
Shanghai
2025-07-29
Recruiting
Iparomlimab and Tuvonralimab in HNSCC
NCT07090317Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
30
Shanghai
2025-07-29
Recruiting
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519Ulcerative Colitis
AbbVie
Phase 3
120
Guangzhou, Zhengzhou, Changsha, Changchun, Shanghai, Hangzhou
2025-07-28
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
Eli Lilly and Company
Phase 1
240
Chengdu, Shanghai, Wuhan
2025-07-28
Recruiting
A Study of BL-B01D1+TKIยฑPembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
NCT06962787Renal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
260
Shanghai
2025-07-28
Not yet open
EEG-TMS Intervening Against Postoperative Delirium
NCT07100197Postoperative Delirium
RenJi Hospital
Not applicable
98
Shanghai
2025-07-27
Active, closed
AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP๏ผ‰
NCT07082049Prostate Cancer
Fudan University
Not applicable
160
Shanghai
2025-07-27
Recruiting
Shanghai Clinical Cohort - Adrenal Disease
NCT07191951Adrenal Disease
Shanghai Jiao Tong University School of Medicine
Observational
600
Shanghai
2025-07-25
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
NCT06807268Eczema
Pfizer
Phase 3
150
Beijing, Shenzhen, Changsha, Nanchang, Shanghai, Hangzhou
2025-07-24
Recruiting
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
NCT07213765Mycobacterium Avium Complex Pulmonary Disease
Bin Cao
Phase 4
188
Hefei, Beijing, Guangzhou, Nanchang, Shanghai
2025-07-24
Recruiting
Prevention of Recurrence With Cordyceps Sinensis in Mycobacterium Avium Complex Pulmonary Disease
NCT07174076Mycobacterium Avium Complex Pulmonary Disease
Bin Cao
Phase 4
300
Hefei, Beijing, Guangzhou, Nanchang, Shanghai
2025-07-24
Recruiting
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
NCT07203404SLE, LN, ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis
Nanjing Bioheng Biotech Co., Ltd.
Phase EARLY_PHASE1
96
Shanghai
2025-07-24
Not yet open
A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
NCT06913218Pancreas Cancer, Pancreas Cancer, Duct Cell Adenocarcinoma
Akeso
Phase 1
60
Shanghai
2025-07-22
Recruiting
A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors
NCT07068932Malignant Tumors of Adults
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
102
Shanghai
2025-07-22
Recruiting
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
NCT07288957Solid Tumors (Phase 1)
Abbisko Therapeutics Co, Ltd
Phase 1
266
Shanghai
2025-07-22
Recruiting
MHB018A Treatment in Patients With Active Thyroid Eye Disease
NCT06989918Thyroid Associated Ophthalmopathies
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
108
Shanghai
2025-07-22
Recruiting
Incidence of 106TBL Lymph Node Metastasis
NCT07165210Esophageal Cancer
Fudan University
Observational
1,852
Shanghai
2025-07-21
Recruiting
Discovery and Validation of Periodontitis Biomarkers
NCT07293481Periodontitis, Biomarker in Early Diagnosis, Saliva
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
228
Shanghai
2025-07-21
Recruiting
Incidence of 107 Lymph Node Metastasis
NCT07165184Esophageal Cancer
Fudan University
Observational
1,100
Shanghai
2025-07-21
Recruiting
Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
NCT07074379Painless Chronic Pancreatitis
Changhai Hospital
Not applicable
126
Shanghai
2025-07-21
Not yet open
Individualized rTMS Synchronized Task Training for Closed-loop Neuromodulation of Post-stroke Motor Dysfunction
NCT07049211Upper Extremity Dysfunction After the Stroke
Ruijin Hospital
Not applicable
51
Shanghai
2025-07-20
Recruiting
DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)
NCT07070440Non Small Cell Lung Cancer
Dizal Pharmaceuticals
Phase 1/2
180
Shanghai
2025-07-16
Recruiting
Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation
NCT07122336Persistent Atrial Fibrillation
Shanghai Chest Hospital
Not applicable
384
Shanghai
2025-07-16
Active, closed
A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs
NCT07018453Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
173
Chongqing, Shanghai
2025-07-16
Recruiting
PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
NCT07167264Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2025-07-16
Recruiting
Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations
NCT07025018Gliomas Harboring IDH1 and/or IDH2 Mutations
Hutchmed
Phase 1
52
Shanghai
2025-07-15
Not yet open
Comparison of Corticosteroid Injection, Nighttime Splinting, or Their Combination for Initial Treatment of Moderate-to-Severe Carpal Tunnel Syndrome
NCT07043179Carpal Tunnel Syndrome (CTS)
Yun Qian
Not applicable
318
Jinjiang, Yancheng, Shanghai
2025-07-15
Active, closed
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)
NCT06963710Chronic Hepatitis B Infection
Aligos Therapeutics
Phase 2
200
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Shanghai
2025-07-15
Not yet open
Clinical Investigation of Sympathetic Nerve Width Measurement in Thoracoscopic Sympathectomy
NCT07047859Thoracoscopic Sympathectomy (ETS)
Tongji University
Observational
1,000
Shanghai
2025-07-15
Not yet open
Instant Flush Redness Clinical Efficacy Study
NCT07067476Sensitive Skin
ChinaNorm
Not applicable
60
Shanghai
2025-07-15
Recruiting
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
NCT07317609Esophageal Squamous Cell Carcinoma (ESCC)
Shanghai Zhongshan Hospital
Phase 1
60
Shanghai
2025-07-15
Recruiting
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
NCT07063030Retinal Dystrophy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
13
Shanghai
2025-07-15
Recruiting
The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy
NCT06818851Diabetes Mellitus, Type 2
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
64
Shanghai
2025-07-14
Recruiting
Study of GV20-0251 in Participants With Solid Tumor Malignancies
NCT07070518Solid Tumor Cancer, Adult Refractory Cancer, Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma
GV20 Therapeutics
Phase 1/2
350
Beijing, Shanghai
2025-07-11
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
NCT07011732Alzheimer Disease
Bristol-Myers Squibb
Phase 3
426
Beijing, Haidian District, Chongqing, Guangzhou, Shenzhen, Changsha, Nanjing, Shanghai
2025-07-10
Recruiting
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
NCT07060378Lung Lesions, Mediastinal and Hilar Lymph Node Enlargement
Shanghai Chest Hospital
Not applicable
250
Shanghai
2025-07-10
Not yet open
A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
NCT07043218B-cell Acute Lymphoblastic Leukemia
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase 1
36
Shanghai
2025-07-10
Recruiting
A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
NCT07070323T-Cell Acute Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia, T-cell Malignancies
Beijing GoBroad Hospital
Phase 1/2
54
Beijing, Shanghai, Chengdu
2025-07-09
Recruiting
Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
NCT06928389Non-Small Cell Lung Cancer
Akeso
Phase 3
536
Shanghai
2025-07-08
Recruiting
A Randomized, Open-label, Multi-center Phase III Study Comparing the Efficacy of Oral Chemotherapy Combined With Trastuzumab Versus Paclitaxel Combined With Trastuzumab in the Adjuvant Treatment of HER2-positive, Lymph Node-negative Early Breast Cancer Patients(ORCHID-PLUS)
NCT06992882HER2-positive Breast Cancer
Fudan University
Phase 3
2,306
Shanghai
2025-07-08
Recruiting
Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
NCT07823049Pancreatic Cancer
Evopoint Biosciences Inc.
Phase 3
226
Shanghai, Beijing, Binzhou, Changsha, Changzhou, Chengdu, Chongqing, Fuyang
2025-07-08
Recruiting
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
NCT06975722Ulcerative Colitis
Sanofi
Phase 2
99
Huizhou, Guangzhou, Nanjing, Suzhou, Wuxi, Shanghai, Hangzhou, Ningbo
2025-07-07
Recruiting
Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss
NCT07024524Congenital Hearing Loss, Gene Therapy, Speech Perception, Rehabilitation
Eye & ENT Hospital of Fudan University
Not applicable
210
Shanghai
2025-07-04
Recruiting
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
NCT06963814Advanced Cancer
HC Biopharma Inc.
Phase 1
252
Shanghai
2025-07-04
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
NCT07612891Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer, Ovarian Cancer
Shenzhen Ionova Life Sciences Co., Ltd.
Phase 1/2
201
Shanghai
2025-07-04
By invitation
Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy
NCT07478198Facial Skin Laxity
Shanghai Punan Hospital of Pudong New District
Not applicable
22
Shanghai
2025-07-03
Recruiting
Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder
NCT07198594Obsessive Compulsive Disorder (OCD), Obsessive - Compulsive Disorder
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Not applicable
20
Shanghai
2025-07-03
Recruiting
Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
NCT07047586Hepatocellular Carcinoma (HCC)
Fudan University
Phase 2
146
Shanghai
2025-07-02
Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
NCT06859762Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1
630
Beijing, Guangzhou, Harbin, Nanchang, Shenyang, Jinan, Shanghai, Tianjin
2025-07-02
Recruiting
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
NCT07053358Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
10
Shanghai
2025-07-02
Recruiting
RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs
NCT06962436Peripheral Pulmonary Nodules
Shanghai Chest Hospital
Not applicable
186
Jinan, Shanghai, Hangzhou
2025-07-02
Active, closed
EndoVascular Aortic Dissection Early vs Delayed
NCT07143071Aortic Dissection Type B
Shanghai Zhongshan Hospital
Observational
4,068
Shanghai
2025-07-01
Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
NCT07043166Metabolic Syndrome, Diabetes, Obesity and Overweight, Hypertension
Shanghai Changzheng Hospital
Observational
4,094
Shanghai
2025-07-01
Not yet open
Evaluation of the Efficacy and Safety of Absorbable vs Traditional Bone Wax for Facet Fusion After Lumbar Fusion Surgery
NCT07040293Lumbar Fusion Surgery, Fusion of Joint
Shanghai Changzheng Hospital
Not applicable
330
Shanghai
2025-07-01
Recruiting
Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients
NCT07064109ACS - Acute Coronary Syndrome
Shanghai Tongji Hospital, Tongji University School of Medicine
Not applicable
380
Shanghai
2025-07-01
Active, closed
OCT in Endovascular Recanalization of Chronic Carotid Artery Occlusion
NCT07740408Chronic Internal Carotid Artery Occlusion, Carotid Artery Occlusion
RenJi Hospital
Observational
60
Shanghai
2025-07-01
Recruiting
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
NCT07309289Metastatic Colorectal Cancer (CRC)
Shanghai Zhongshan Hospital
Phase 3
144
Shanghai
2025-07-01
Not yet open
REST4-AAA Registry
NCT07056491Abdominal Aortic Aneurysm
RenJi Hospital
Observational
70
Shanghai
2025-07-01
Not yet open
Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy
NCT07036939Multiple System Atrophy
Ruijin Hospital
Not applicable
46
Shanghai
2025-07-01
Recruiting
Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment
NCT07199296Mantle Cell Lymphoma (MCL)
Ruijin Hospital
Phase 2
45
Shanghai
2025-07-01
Recruiting
Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment
NCT07067385Personalized Neoantigen Vaccine in Combination With Anti-PD-1 Inhibitors in Standard Therapy-Failed and Adjuvant Therapy, Gastrointestinal Tumors
Ruijin Hospital
Phase 1
40
Shanghai
2025-07-01
Recruiting
Electroacupuncture on Treating Cancer-related Depression
NCT07003763Depression, Cancer
Shanghai Municipal Hospital of Traditional Chinese Medicine
Not applicable
86
Shanghai
2025-07-01
Not yet open
The 22G Franseen Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy
NCT07023549Pancreatic Diseases
Changhai Hospital
Not applicable
270
Shanghai
2025-07-01
Recruiting
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
NCT06311955Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray, Heavy Ion Radiotherapy
Jian Chen
Phase 2
48
Shanghai
2025-07-01
Not yet open
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
NCT07030621Acute Ischemic Stroke
RenJi Hospital
Phase 3
436
Shanghai
2025-07-01
Not yet open
Optical Biopsy and Cytological Evaluation for Intrathoracic Lymphadenopathy
NCT07047417Intrathoracic Lymphadenopathy
Shanghai Chest Hospital
Not applicable
150
Shanghai
2025-07-01
Not yet open
The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC
NCT06965829Esophageal Cancer Stage III
Shanghai Chest Hospital
Phase 2
40
Shanghai
2025-07-01
Recruiting
AI-Driven Multimodal Imaging Integration for Diagnosis and Prognostication of Digestive System Diseases
NCT07087418Digestive Diseases, Radiology, AI (Artificial Intelligence), Imaging
First Affiliated Hospital, Sun Yat-Sen University
Observational
5,000
Shanghai
2025-07-01
Not yet open
A Cohort Study on Treating Primary Nocturnal Enuresis by Regulating Central-Peripheral Circadian Rhythm
NCT07003126Primary Nocturnal Enuresis
Shanghai Children's Medical Center
Not applicable
200
Shanghai
2025-07-01
By invitation
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
NCT07050134Hypertriglyceridemia, Carotid Atherosclerotic Plaques
Junbo Ge
Not applicable
40
Hefei, Suzhou, Shanghai
2025-07-01
Recruiting
REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease
NCT06936111Coronary Heart Disease (CHD)
Shanghai Zhongshan Hospital
Observational
900
Shanghai
2025-07-01
Not yet open
Intervention Study on Digital Health Management
NCT06949306Hypertension, Hyperlipidemia
Shanghai 10th People's Hospital
Not applicable
300
Shanghai
2025-07-01
Recruiting
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
NCT07047339Colitis, IBD (Inflammatory Bowel Disease), Probiotic Intervention
Changhai Hospital
Phase 2/3
120
Shanghai
2025-07-01
Recruiting
The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma
NCT07073833Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 1
40
Hangzhou, Shanghai
2025-07-01
Not yet open
DCB for CAD With Type 2 Diabetes
NCT07009938Coronary Artery Disease, Diabete Type 2
Shanghai 10th People's Hospital
Not applicable
1,000
Kaifeng, Luoyang, Zhengzhou, Shanghai, Yibin, Ningbo
2025-07-01
Not yet open
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
NCT07035821Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients, Pediatric Cancer
Shanghai Children's Medical Center
Phase 3
100
Shanghai
2025-07-01
Not yet open
Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients
NCT06999252Colon Cancer
Fudan University
Phase 2
20
Shanghai
2025-07-01
Not yet open
A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
NCT07026123Advanced Pancreatic Cancer
RenJi Hospital
Observational
40
Shanghai
2025-07-01
Recruiting
EGR2 and NLRP3 Pathways in Obstructive Sleep Apnea-Related Cognitive and Mood Disorders
NCT07120711Obstructive Sleep Apnea-Hypopnea Syndrome, Anxiety Disorders, Depressive Disorders
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2025-07-01
Not yet open
Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer
NCT06973421Platinum Resistant Ovarian Cancer
Fudan University
Phase 2
35
Shanghai
2025-07-01
Active, closed
Multicenter Clinical Randomized Controlled Trial of Unilateral Biportal Endoscopic Spinal Surgery for Degenerative Grade 1 Spondylolisthesis Complicated With Lumbar Spinal Stenosis
NCT07303348Lumbar Spinal Stenosis (LSS), Degenerative Spondylolisthesis G1
Changhai Hospital
Not applicable
200
Shanghai
2025-07-01
Rows per page Showing 1301–1400 of 3827
Previous 12 13 14 15 16 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=14

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.